Home | Technology transformation
In this issue
Contents
SHL Medical Company Insight
SHL Medical
Datwyler Company Insight
Datwyler
CSafe Global
Briefing
Industry news
The pharma industry briefing
Mimotopes Company Insight
Mimotopes
Comment
Tapping into pharma’s growing opportunities in digital health
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Implementation of electronic health records will improve the quality of care
Despite benefits, long-acting injectables remain underutilised for schizophrenia
FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
UK health data collaboration paves the way to study Long Covid symptoms
Molnar-Institute Company Insight
Molnar-Institute
In Depth
A makeover for NICE: a new look for HTAs in the UK
No drugs for prions: investigating new approaches to alleviate therapeutic scarc
Getting smart with digital pills
Do generics producers have what it takes to tackle complex and specialty drugs?
Decentralised paediatric clinical trials trending up but study execution critica
CMO Moves: Regulatory catalysts for drug manufacturing—August
Biolife Solutions
In Data
Healthtech deals decreased significantly in the pharma industry in H1 2022
North America is seeing a hiring boom in pharmaceutical industry machine learnin
Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
Digital media hiring levels in the pharmaceutical industry rose in June 2022
Events
Next issue
08/22/2022 00:00:00
Go to article:
Home | Technology transformation
Go to article:
In this issue
Go to article:
Contents
Go to article:
SHL Medical Company Insight
Go to article:
SHL Medical
Go to article:
Datwyler Company Insight
Go to article:
Datwyler
Go to article:
CSafe Global
Go to article:
Briefing
Go to article:
Industry news
Go to article:
The pharma industry briefing
Go to article:
Mimotopes Company Insight
Go to article:
Mimotopes
Go to article:
Comment
Go to article:
Tapping into pharma’s growing opportunities in digital health
Go to article:
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Go to article:
Implementation of electronic health records will improve the quality of care
Go to article:
Despite benefits, long-acting injectables remain underutilised for schizophrenia
Go to article:
FDA approves Coherus’ Cimerli for DME, with year-long interchangeability exclusivity
Go to article:
UK health data collaboration paves the way to study Long Covid symptoms
Go to article:
Molnar-Institute Company Insight
Go to article:
Molnar-Institute
Go to article:
In Depth
Go to article:
A makeover for NICE: a new look for HTAs in the UK
Go to article:
No drugs for prions: investigating new approaches to alleviate therapeutic scarc
Go to article:
Getting smart with digital pills
Go to article:
Do generics producers have what it takes to tackle complex and specialty drugs?
Go to article:
Decentralised paediatric clinical trials trending up but study execution critica
Go to article:
CMO Moves: Regulatory catalysts for drug manufacturing—August
Go to article:
Biolife Solutions
Go to article:
In Data
Go to article:
Healthtech deals decreased significantly in the pharma industry in H1 2022
Go to article:
North America is seeing a hiring boom in pharmaceutical industry machine learnin
Go to article:
Artificial intelligence mentions decrease in pharma filings in Q2 of 2022
Go to article:
Digital media hiring levels in the pharmaceutical industry rose in June 2022
Go to article:
Events
Go to article:
Next issue